News Sentiment

INCY sentiment intelligence

Incyte Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 53 Balanced news tone 36 relevant articles
Exchange MEX Mexico
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2067.00 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 36

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+0.0% over one week, +23.3% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Is Halozyme ENHANZE Deal Reshaping Subcutaneous Antibody Delivery For Incyte’s Pipeline Strategy (INCY)?

Market Reaction

Balanced read

52/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive 23.3% over four weeks
Fair value 40.6% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 7
Neutral 27
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 36
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Investing.com 15
Stock Titan 8
Market source 6
Barchart.com 2
simplywall.st 1
ChartMill 1
Investing.com Canada 1
Investing.com Nigeria 1

Event Lens

What the news is about

Classified themes
Market update 21
Analyst action 8
Earnings 6
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 36